172 related articles for article (PubMed ID: 35675168)
21. Macrophage extracellular traps require peptidylarginine deiminase 2 and 4 and are a source of citrullinated antigens bound by rheumatoid arthritis autoantibodies.
Bashar SJ; Holmes CL; Shelef MA
Front Immunol; 2024; 15():1167362. PubMed ID: 38476240
[TBL] [Abstract][Full Text] [Related]
22. Anti-Peptidylarginine Deiminase 4 Autoantibodies and Disease Duration as Predictors of Treatment Response in Rheumatoid Arthritis.
Cappelli LC; Hines D; Wang H; Bingham CO; Darrah E
ACR Open Rheumatol; 2024 Feb; 6(2):81-90. PubMed ID: 38058274
[TBL] [Abstract][Full Text] [Related]
23. Association of cross-reactive antibodies targeting peptidyl-arginine deiminase 3 and 4 with rheumatoid arthritis-associated interstitial lung disease.
Giles JT; Darrah E; Danoff S; Johnson C; Andrade F; Rosen A; Bathon JM
PLoS One; 2014; 9(6):e98794. PubMed ID: 24901704
[TBL] [Abstract][Full Text] [Related]
24. Lack of Association among Peptidyl Arginine Deiminase Type 4 Autoantibodies,
Guderud K; Mæhlen MT; Nordang GBN; Viken MK; Andreassen BK; Molberg Ø; Flåm ST; Lie BA
J Rheumatol; 2018 Aug; 45(9):1211-1219. PubMed ID: 29858238
[TBL] [Abstract][Full Text] [Related]
25. Predominance of IgG1 and IgG3 subclasses of autoantibodies to peptidylarginine deiminase 4 in rheumatoid arthritis.
Wang W; Li J
Clin Rheumatol; 2011 Apr; 30(4):563-7. PubMed ID: 21210288
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic values, association with disease activity and possible risk factors of anti-PAD4 in rheumatoid arthritis: a meta-analysis.
Zhang G; Xu J; Du D; Liu Y; Dai L; Zhao Y
Rheumatology (Oxford); 2024 Apr; 63(4):914-924. PubMed ID: 37824204
[TBL] [Abstract][Full Text] [Related]
27. Serum IgG antibodies to peptidylarginine deiminase 4 predict radiographic progression in patients with rheumatoid arthritis treated with tumour necrosis factor-alpha blocking agents.
Halvorsen EH; Haavardsholm EA; Pollmann S; Boonen A; van der Heijde D; Kvien TK; Molberg Ø
Ann Rheum Dis; 2009 Feb; 68(2):249-52. PubMed ID: 18723564
[TBL] [Abstract][Full Text] [Related]
28. Association of autoimmunity to peptidyl arginine deiminase type 4 with genotype and disease severity in rheumatoid arthritis.
Harris ML; Darrah E; Lam GK; Bartlett SJ; Giles JT; Grant AV; Gao P; Scott WW; El-Gabalawy H; Casciola-Rosen L; Barnes KC; Bathon JM; Rosen A
Arthritis Rheum; 2008 Jul; 58(7):1958-67. PubMed ID: 18576335
[TBL] [Abstract][Full Text] [Related]
29. Erosive rheumatoid arthritis is associated with antibodies that activate PAD4 by increasing calcium sensitivity.
Darrah E; Giles JT; Ols ML; Bull HG; Andrade F; Rosen A
Sci Transl Med; 2013 May; 5(186):186ra65. PubMed ID: 23698378
[TBL] [Abstract][Full Text] [Related]
30. Iguratimod dose dependently inhibits the expression of citrullinated proteins and peptidylarginine deiminases 2 and 4 in neutrophils from rheumatoid arthritis patients.
Li B; Li P; Bi L
Clin Rheumatol; 2020 Mar; 39(3):899-907. PubMed ID: 31758423
[TBL] [Abstract][Full Text] [Related]
31. Expression of anti-Porphyromonas gingivalis peptidylarginine deiminase immunoglobulin G and peptidylarginine deiminase-4 in patients with rheumatoid arthritis and periodontitis.
Shimada A; Kobayashi T; Ito S; Okada M; Murasawa A; Nakazono K; Yoshie H
J Periodontal Res; 2016 Feb; 51(1):103-11. PubMed ID: 26094771
[TBL] [Abstract][Full Text] [Related]
32. Immunoglobulin (Ig)G1 and IgG4 anti-cyclic citrullinated peptide (CCP) associate with shared epitope, whereas IgG2 anti-CCP associates with smoking in patients with recent-onset rheumatoid arthritis (the Swedish TIRA project).
Martinsson K; Johansson A; Kastbom A; Skogh T
Clin Exp Immunol; 2017 Apr; 188(1):53-62. PubMed ID: 27859022
[TBL] [Abstract][Full Text] [Related]
33. The lack of association between PADI4_94 or PADI4_104 polymorphisms and RF, ACPA and anti-PAD4 in patients with rheumatoid arthritis.
Ciesla M; Kolarz B; Darmochwal-Kolarz D
Sci Rep; 2022 Jul; 12(1):11882. PubMed ID: 35831381
[TBL] [Abstract][Full Text] [Related]
34. Defining the role of Porphyromonas gingivalis peptidylarginine deiminase (PPAD) in rheumatoid arthritis through the study of PPAD biology.
Konig MF; Paracha AS; Moni M; Bingham CO; Andrade F
Ann Rheum Dis; 2015 Nov; 74(11):2054-61. PubMed ID: 24864075
[TBL] [Abstract][Full Text] [Related]
35. Anti-Protein-Arginine Deiminase 4 IgG and IgA Delineate Severe Rheumatoid Arthritis.
Martinez-Prat L; Martinez-Taboada V; Santos C; Lopez-Hoyos M; Mahler M
Diagnostics (Basel); 2022 Sep; 12(9):. PubMed ID: 36140588
[TBL] [Abstract][Full Text] [Related]
36. Meta-analysis: diagnostic accuracy of antibody against peptidylarginine deiminase 4 by ELISA for rheumatoid arthritis.
Ren J; Sun L; Zhao J
Clin Rheumatol; 2017 Nov; 36(11):2431-2438. PubMed ID: 28887697
[TBL] [Abstract][Full Text] [Related]
37. Autoantibodies to protein-arginine deiminase (PAD) 4 in rheumatoid arthritis: immunological and clinical significance, and potential for precision medicine.
Martinez-Prat L; Palterer B; Vitiello G; Parronchi P; Robinson WH; Mahler M
Expert Rev Clin Immunol; 2019 Oct; 15(10):1073-1087. PubMed ID: 31524005
[No Abstract] [Full Text] [Related]
38. Serum IgG antibodies to peptidylarginine deiminase 4 in rheumatoid arthritis and associations with disease severity.
Halvorsen EH; Pollmann S; Gilboe IM; van der Heijde D; Landewé R; Ødegård S; Kvien TK; Molberg Ø
Ann Rheum Dis; 2008 Mar; 67(3):414-7. PubMed ID: 18006540
[TBL] [Abstract][Full Text] [Related]
39. Reduced Anti-Histone Antibodies and Increased Risk of Rheumatoid Arthritis Associated with a Single Nucleotide Polymorphism in PADI4 in North Americans.
Mergaert AM; Bawadekar M; Nguyen TQ; Massarenti L; Holmes CL; Rebernick R; Schrodi SJ; Shelef MA
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31242568
[TBL] [Abstract][Full Text] [Related]
40. PAD enzymes in rheumatoid arthritis: pathogenic effectors and autoimmune targets.
Curran AM; Naik P; Giles JT; Darrah E
Nat Rev Rheumatol; 2020 Jun; 16(6):301-315. PubMed ID: 32341463
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
